Glenmark Pharma gets USFDA nod for seizure treatment drug

Shares of Glenmark Pharmaceuticals were trading 1.02% higher at Rs 656.10 apiece on the BSE

from Latest News http://bit.ly/2TaCJvR
https://ift.tt/eA8V8J http://bit.ly/2SdCH5P

• Tweet
• Share
• Share
• Share
• Share